Budget impact analysis ofCYP2C19-guided voriconazole prophylaxis in AML-Reference-Cited by-同舟云学术

Budget impact analysis ofCYP2C19-guided voriconazole prophylaxis in AML

Published:2015-08-01 Issue:11 Volume:70 Page:3124-3126
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:J. Antimicrob. Chemother.

Author:

Mason Neil T.,Bell Gillian C.,Quilitz Rod E.,Greene John N.,McLeod Howard L.

Funder

DeBartolo Family Personalized Medicine Institute

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/70/11/3124/17429700/dkv224.pdf

Reference18 articles.

1. Aspergillosis Case-Fatality Rate: Systematic Review of the Literature

2. Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia

3. ANDA (Generic) Drug Approvals. First-Time Generics - April 2010. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/DrugandBiologicApprovalReports/ANDAGenericDrugApprovals/ucm212811.htm .

4. Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical application of voriconazole in pediatric patients: a systematic review;Italian Journal of Pediatrics;2024-06-09

2. Advances in pharmacogenomics for personalized emergency medicine;International journal of health sciences;2023-01-15

3. Optimization of Antimicrobial Stewardship Programs Using Therapeutic Drug Monitoring and Pharmacokinetics–Pharmacodynamics Protocols: A Cost-Benefit Review;Therapeutic Drug Monitoring;2023-01-02

4. Genetic Contributions and Personalized Medicine;Chronic Illness Care;2023

5. Cost Effectiveness of Pharmacogenetic Testing for Drugs with Clinical Pharmacogenetics Implementation Consortium ( CPIC ) Guidelines: A Systematic Review;Clinical Pharmacology & Therapeutics;2022-10-09